A Study to Evaluate Lenalidomide Combined With Dexamethasone in Relapsed or Refractory Diffuse Large B-Cell Lymphoma
Status:
Terminated
Trial end date:
2008-12-01
Target enrollment:
Participant gender:
Summary
To evaluate the safety and efficacy of lenalidomide (Revlimid ®) in combination with
dexamethasone in subjects with relapsed or refractory diffuse large B-cell lymphoma.